×
S&P 500   3,820.84 (+0.94%)
DOW   31,064.50 (+0.94%)
QQQ   282.25 (+0.70%)
AAPL   138.68 (+1.43%)
MSFT   259.68 (+1.11%)
META   159.87 (-0.86%)
GOOGL   2,174.54 (-0.22%)
AMZN   109.61 (+3.20%)
TSLA   679.75 (+0.94%)
NVDA   145.26 (-4.18%)
NIO   21.40 (-1.47%)
BABA   116.08 (+2.11%)
AMD   73.75 (-3.56%)
MU   53.62 (-3.00%)
CGC   2.82 (-1.05%)
T   21.36 (+1.91%)
GE   63.81 (+0.22%)
F   11.31 (+1.62%)
DIS   96.18 (+1.89%)
AMC   13.47 (-0.59%)
PFE   52.32 (-0.21%)
PYPL   71.46 (+2.32%)
NFLX   179.97 (+2.92%)
S&P 500   3,820.84 (+0.94%)
DOW   31,064.50 (+0.94%)
QQQ   282.25 (+0.70%)
AAPL   138.68 (+1.43%)
MSFT   259.68 (+1.11%)
META   159.87 (-0.86%)
GOOGL   2,174.54 (-0.22%)
AMZN   109.61 (+3.20%)
TSLA   679.75 (+0.94%)
NVDA   145.26 (-4.18%)
NIO   21.40 (-1.47%)
BABA   116.08 (+2.11%)
AMD   73.75 (-3.56%)
MU   53.62 (-3.00%)
CGC   2.82 (-1.05%)
T   21.36 (+1.91%)
GE   63.81 (+0.22%)
F   11.31 (+1.62%)
DIS   96.18 (+1.89%)
AMC   13.47 (-0.59%)
PFE   52.32 (-0.21%)
PYPL   71.46 (+2.32%)
NFLX   179.97 (+2.92%)
S&P 500   3,820.84 (+0.94%)
DOW   31,064.50 (+0.94%)
QQQ   282.25 (+0.70%)
AAPL   138.68 (+1.43%)
MSFT   259.68 (+1.11%)
META   159.87 (-0.86%)
GOOGL   2,174.54 (-0.22%)
AMZN   109.61 (+3.20%)
TSLA   679.75 (+0.94%)
NVDA   145.26 (-4.18%)
NIO   21.40 (-1.47%)
BABA   116.08 (+2.11%)
AMD   73.75 (-3.56%)
MU   53.62 (-3.00%)
CGC   2.82 (-1.05%)
T   21.36 (+1.91%)
GE   63.81 (+0.22%)
F   11.31 (+1.62%)
DIS   96.18 (+1.89%)
AMC   13.47 (-0.59%)
PFE   52.32 (-0.21%)
PYPL   71.46 (+2.32%)
NFLX   179.97 (+2.92%)
S&P 500   3,820.84 (+0.94%)
DOW   31,064.50 (+0.94%)
QQQ   282.25 (+0.70%)
AAPL   138.68 (+1.43%)
MSFT   259.68 (+1.11%)
META   159.87 (-0.86%)
GOOGL   2,174.54 (-0.22%)
AMZN   109.61 (+3.20%)
TSLA   679.75 (+0.94%)
NVDA   145.26 (-4.18%)
NIO   21.40 (-1.47%)
BABA   116.08 (+2.11%)
AMD   73.75 (-3.56%)
MU   53.62 (-3.00%)
CGC   2.82 (-1.05%)
T   21.36 (+1.91%)
GE   63.81 (+0.22%)
F   11.31 (+1.62%)
DIS   96.18 (+1.89%)
AMC   13.47 (-0.59%)
PFE   52.32 (-0.21%)
PYPL   71.46 (+2.32%)
NFLX   179.97 (+2.92%)
NASDAQ:APTO

Aptose Biosciences Earnings Date, Estimates & Call Transcripts (2022)

$0.80
+0.06 (+7.54%)
(As of 07/1/2022 03:34 PM ET)
Add
Compare
Today's Range
$0.77
$0.81
50-Day Range
$0.74
$1.22
52-Week Range
$0.73
$3.43
Volume
5,249 shs
Average Volume
394,832 shs
Market Capitalization
$73.41 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.00

Earnings Summary

Upcoming
Earnings Date
Aug. 2Estimated
Actual EPS
(May. 9)
-$0.12 Beat By $0.03
Consensus EPS
(May. 9)
-$0.15
Last Year's Q2 EPS
(5/4/2021)
-$0.18
Skip Charts & View Estimated and Actual Earnings Data

APTO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

APTO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Aptose Biosciences Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20222($0.13)($0.13)($0.13)
Q2 20222($0.14)($0.13)($0.14)
Q3 20222($0.15)($0.13)($0.14)
Q4 20222($0.15)($0.13)($0.14)
FY 20228($0.57)($0.52)($0.55)
Q1 20231($0.16)($0.16)($0.16)
Q2 20231($0.17)($0.17)($0.17)
Q3 20231($0.18)($0.18)($0.18)
Q4 20231($0.19)($0.19)($0.19)
FY 20234($0.70)($0.70)($0.70)

APTO Earnings Date and Information

Aptose Biosciences last released its earnings data on May 9th, 2022. The biotechnology company reported ($0.12) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.15) by $0.03. Aptose Biosciences has generated ($0.67) earnings per share over the last year (($0.67) diluted earnings per share). Earnings for Aptose Biosciences are expected to decrease in the coming year, from ($0.57) to ($0.60) per share. Aptose Biosciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 2nd, 2022 based off prior year's report dates.

Aptose Biosciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/2/2022
(Estimated)
        
5/9/2022Q1 2022($0.15)($0.12)+$0.03($0.12)    
3/22/2022Q4 2021($0.18)($0.27)($0.09)($0.27)    
11/11/20219/30/2021($0.17)($0.13)+$0.04($0.13)    
8/2/20216/30/2021($0.19)($0.15)+$0.04($0.15)    
5/4/20213/31/2021($0.17)($0.18)($0.01)($0.18)  
3/22/202112/31/2020($0.17)($0.16)+$0.01($0.17)  
11/15/2020Q3($0.18)($0.15)+$0.03($0.15)  
8/4/20206/30/2020($0.15)($0.21)($0.06)($0.21)  
5/5/20203/31/2020($0.10)($0.15)($0.05)($0.15)  
3/10/202012/31/2019($0.14)($0.13)+$0.01($0.13)  
11/5/2019Q3($0.13)($0.12)+$0.01($0.12)  
8/6/2019Q2($0.14)($0.13)+$0.01($0.13)  
5/7/20193/31/2019($0.17)($0.14)+$0.03($0.14)  
3/12/201912/31/2018($0.16)($0.17)($0.01)($0.17)  
11/6/20189/30/2018($0.19)($0.16)+$0.03($0.16)
8/7/20186/30/2018($0.20)($0.30)($0.10)($0.30)
5/10/2018Q1 2018($0.12)($0.23)($0.11)($0.23)
3/27/2018Q4 2017($0.11)($0.12)($0.01)($0.12)
11/14/2017Q3 2017($0.13)($0.11)+$0.02($0.11)
8/8/2017Q2($0.18)($0.11)+$0.07($0.11)  
5/11/2017Q1 2017($0.19)($0.19)($0.19)
3/28/2017Q4 2016($0.19)($0.19)($0.19)
11/14/2016Q3 2016($0.36)($0.24)+$0.12($0.24)
8/9/2016Q2 2016($0.32)($0.36)($0.04)($0.36)
5/10/2016Q1 2016($0.30)($0.31)($0.01)($0.31)
3/29/2016Q415($0.28)($0.38)($0.10)($0.29)
11/10/2015Q315($0.33)($0.27)+$0.06($0.21)
8/4/2015Q215($0.31)($0.22)+$0.09($0.22)
5/5/2015Q1 2015($0.31)($0.25)+$0.06($0.25)
3/3/2015Q4 2014($0.31)($0.25)+$0.06($0.25)
11/5/2014Q3 2014($0.32)($0.32)($0.32)
7/15/2014Q2 2014($0.24)($0.48)($0.24)($0.51)
4/10/2014Q1 2014($0.72)($0.48)+$0.24($0.48)
1/7/2014Q4 2013($0.72)($0.72)($0.72)
10/15/2013Q3 2013($0.36)($0.36)($0.36)
7/15/2013Q2 2013($0.36)($0.36)($0.36)
4/12/2013Q1 2013($0.36)($0.36)($0.36)
1/14/2013Q4 2012($0.48)($0.48)($0.48)
10/15/2012Q3 2012($0.36)($0.36)($0.36)
8/8/2012Q2 2012$0.60+$0.60$0.60
4/12/2012Q1 2012($0.58)($0.58)($0.58)
1/13/2012Q4 2011($0.82)($0.82)($0.82)
11/11/2011Q3 2011($0.76)($0.76)($0.76)
8/26/2011Q2 2011($0.73)($0.73)($0.73)
1/14/2011Q4 2010($1.34)($1.34)($1.34)
10/15/2010Q3 2010($1.38)($1.38)($1.38)
8/30/2010Q2 2010($2.16)($2.16)($2.16)
1/14/2009Q4 2008$4.41+$4.41$4.41
10/9/2008Q3 2008$3.24+$3.24$3.24
4/14/2008Q1 2008$6.49+$6.49$6.49
1/8/2008Q4 2007($4.69)($4.69)($4.69)












Aptose Biosciences Earnings - Frequently Asked Questions

When is Aptose Biosciences's earnings date?

Aptose Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 2nd, 2022 based off last year's report dates. Learn more on APTO's earnings history.

Did Aptose Biosciences beat their earnings estimates last quarter?

In the previous quarter, Aptose Biosciences (NASDAQ:APTO) reported ($0.12) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.15) by $0.03. Learn more on analysts' earnings estimate vs. APTO's actual earnings.

How can I listen to Aptose Biosciences's earnings conference call?

The conference call for Aptose Biosciences's latest earnings report can be listened to online. Listen to Conference Call

How can I read Aptose Biosciences's conference call transcript?

The conference call transcript for Aptose Biosciences's latest earnings report can be read online. Read Transcript

How much profit does Aptose Biosciences generate each year?

Aptose Biosciences (NASDAQ:APTO) has a recorded net income of -$65.35 million. APTO has generated -$0.67 earnings per share over the last four quarters.

What is Aptose Biosciences's EPS forecast for next year?

Aptose Biosciences's earnings are expected to decrease from ($0.57) per share to ($0.60) per share in the next year.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:APTO) was last updated on 7/1/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.